SPECTRAL MEDICAL INC

Spectral Medical Inc pioneers Toraymyxin, a theranostic hemoperfusion device targeting sepsis—discover how this Toronto biotech is reshaping critical care.

Spectral Medical Inc. pioneers theranostics for severe sepsis, using Toraymyxin to clear endotoxins and the EUPHRATES trial to boost patient survival.

Spectral Medical Inc. pioneers theranostics for sepsis, showcasing Toraymyxin’s hemoperfusion breakthrough and the pivotal EUPHRATES trial—investors and clinicians alike.

Spectral Medical Inc is pioneering theranostics for sepsis treatment with its flagship product Toraymyxin, a device that removes endotoxins from the bloodstream, and is currently conducting the EUPHRATES trial to further develop this innovative trea…

Spectral Medical Inc is pioneering theranostics for sepsis treatment with its flagship product Toraymyxin, a device designed to remove endotoxins from the bloodstream, and is making significant strides in addressing a critical healthcare challenge.